Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio: 2014-2025

Historic Debt Ratio for Viridian Therapeutics, Inc.\DE (VRDN) over the last 7 years, with Sep 2025 value amounting to 0.04.

  • Viridian Therapeutics, Inc.\DE's Debt Ratio rose 36.14% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year increase of 36.14%. This contributed to the annual value of 0.03 for FY2024, which is 32.71% down from last year.
  • Viridian Therapeutics, Inc.\DE's Debt Ratio amounted to 0.04 in Q3 2025, which was up 1.39% from 0.04 recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Debt Ratio ranged from a high of 0.04 in Q4 2023 and a low of 0.03 during Q3 2024.
  • Moreover, its 3-year median value for Debt Ratio was 0.03 (2024), whereas its average is 0.03.
  • Its Debt Ratio has fluctuated over the past 5 years, first tumbled by 32.71% in 2024, then skyrocketed by 36.14% in 2025.
  • Quarterly analysis of 3 years shows Viridian Therapeutics, Inc.\DE's Debt Ratio stood at 0.04 in 2023, then crashed by 32.71% to 0.03 in 2024, then skyrocketed by 36.14% to 0.04 in 2025.
  • Its Debt Ratio stands at 0.04 for Q3 2025, versus 0.04 for Q2 2025 and 0.03 for Q1 2025.